Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition.
Level 5 - mechanism / opinion, no new human data
Animal research (rodent model)
PubMed 2387245 · doi:10.1210/endo-127-3-1016
What was done
Researchers administered recombinant human tumor necrosis factor alpha (TNF) to rats to evaluate its acute effects on lipoprotein metabolism. They measured plasma levels, particle size, apoprotein and lipid composition, and ultracentrifugal flotation rate of very low density lipoproteins (VLDL) at 90 minutes using nondenaturing gradient gel electrophoresis. They also compared clearance of radioiodinated VLDL to control animals at 90 minutes and tracked intermediate (IDL) and low density lipoproteins (LDL) up to 16 hours.
What was found
Within 90 minutes of TNF administration, plasma VLDL increased rapidly with normal size, composition, and flotation rate. Radioiodinated VLDL clearance at 90 minutes did not differ between TNF-treated rats and controls. Between 90 minutes and 16 hours, VLDL declined as IDL and LDL rose. By 16 hours, LDL protein mass increased by 50% with normal composition and subspecies distribution. Absolute lipoprotein values and statistical dispersion were not reported in the abstract.
Why it matters
The study indicates that TNF-induced acute hypertriglyceridemia is initially mediated by enhanced hepatic VLDL production rather than impaired particle clearance, establishing the liver as a primary acute target of TNF action.
Limits
This is an animal study in rats using recombinant human cytokine, limiting direct human translation. The abstract omits sample size, TNF dose, baseline lipoprotein concentrations, and variance metrics.
Cited by
- supports Pro-inflammatory cytokines including TNF-alpha and interferon stimulate VLDL secretion by the liver within minutes.